Cargando…

Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals

BACKGROUND:  Dementia is a group of symptoms that largely affects older people. The majority of patients face behavioural and psychological symptoms (BPSD) during the course of their illness. Alzheimer’s disease (AD) and vascular dementia (VaD) are two of the most prevalent types of dementia. Availa...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Alok, Todd, Stephen, Finn, David P., McClean, Paula L., Wong-Lin, KongFatt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547465/
https://www.ncbi.nlm.nih.gov/pubmed/36207697
http://dx.doi.org/10.1186/s12911-022-01892-9
_version_ 1784805269928148992
author Joshi, Alok
Todd, Stephen
Finn, David P.
McClean, Paula L.
Wong-Lin, KongFatt
author_facet Joshi, Alok
Todd, Stephen
Finn, David P.
McClean, Paula L.
Wong-Lin, KongFatt
author_sort Joshi, Alok
collection PubMed
description BACKGROUND:  Dementia is a group of symptoms that largely affects older people. The majority of patients face behavioural and psychological symptoms (BPSD) during the course of their illness. Alzheimer’s disease (AD) and vascular dementia (VaD) are two of the most prevalent types of dementia. Available medications provide symptomatic benefits and provide relief from BPSD and associated health issues. However, it is unclear how specific dementia, antidepressant, antipsychotic, antianxiety, and mood stabiliser drugs, used in the treatment of depression and dementia subtypes are prescribed in hospital admission, during hospital stay, and at the time of discharge. To address this, we apply multi-dimensional data analytical approaches to understand drug prescribing practices within hospitals in England and Wales. METHODS: We made use of the UK National Audit of Dementia (NAD) dataset and pre-processed the dataset. We evaluated the pairwise Pearson correlation of the dataset and selected key data features which are highly correlated with dementia subtypes. After that, we selected drug prescribing behaviours (e.g. specific medications at the time of admission, during the hospital stay, and upon discharge), drugs and disorders. Then to shed light on the relations across multiple features or dimensions, we carried out multiple regression analyses, considering the number of dementia, antidepressant, antipsychotic, antianxiety, mood stabiliser, and antiepileptic/anticonvulsant drug prescriptions as dependent variables, and the prescription of other drugs, number of patients with dementia subtypes (AD/VaD), and depression as independent variables. RESULTS: In terms of antidepressant drugs prescribed in hospital admission, during stay and discharge, the number of sertraline and venlafaxine prescriptions were associated with the number of VaD patients whilst the number of mirtazapine prescriptions was associated with frontotemporal dementia patients. During admission, the number of lamotrigine prescriptions was associated with frontotemporal dementia patients, and with the number of valproate and dosulepin prescriptions. During discharge, the number of mirtazapine prescriptions was associated with the number of donepezil prescriptions in conjunction with frontotemporal dementia patients. Finally, the number of prescriptions of donepezil/memantine at admission, during hospital stay and at discharge exhibited positive association with AD patients. CONCLUSION: Our analyses reveal a complex, multifaceted set of interactions among prescribed drug types, dementia subtypes, and depression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01892-9.
format Online
Article
Text
id pubmed-9547465
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95474652022-10-09 Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals Joshi, Alok Todd, Stephen Finn, David P. McClean, Paula L. Wong-Lin, KongFatt BMC Med Inform Decis Mak Research BACKGROUND:  Dementia is a group of symptoms that largely affects older people. The majority of patients face behavioural and psychological symptoms (BPSD) during the course of their illness. Alzheimer’s disease (AD) and vascular dementia (VaD) are two of the most prevalent types of dementia. Available medications provide symptomatic benefits and provide relief from BPSD and associated health issues. However, it is unclear how specific dementia, antidepressant, antipsychotic, antianxiety, and mood stabiliser drugs, used in the treatment of depression and dementia subtypes are prescribed in hospital admission, during hospital stay, and at the time of discharge. To address this, we apply multi-dimensional data analytical approaches to understand drug prescribing practices within hospitals in England and Wales. METHODS: We made use of the UK National Audit of Dementia (NAD) dataset and pre-processed the dataset. We evaluated the pairwise Pearson correlation of the dataset and selected key data features which are highly correlated with dementia subtypes. After that, we selected drug prescribing behaviours (e.g. specific medications at the time of admission, during the hospital stay, and upon discharge), drugs and disorders. Then to shed light on the relations across multiple features or dimensions, we carried out multiple regression analyses, considering the number of dementia, antidepressant, antipsychotic, antianxiety, mood stabiliser, and antiepileptic/anticonvulsant drug prescriptions as dependent variables, and the prescription of other drugs, number of patients with dementia subtypes (AD/VaD), and depression as independent variables. RESULTS: In terms of antidepressant drugs prescribed in hospital admission, during stay and discharge, the number of sertraline and venlafaxine prescriptions were associated with the number of VaD patients whilst the number of mirtazapine prescriptions was associated with frontotemporal dementia patients. During admission, the number of lamotrigine prescriptions was associated with frontotemporal dementia patients, and with the number of valproate and dosulepin prescriptions. During discharge, the number of mirtazapine prescriptions was associated with the number of donepezil prescriptions in conjunction with frontotemporal dementia patients. Finally, the number of prescriptions of donepezil/memantine at admission, during hospital stay and at discharge exhibited positive association with AD patients. CONCLUSION: Our analyses reveal a complex, multifaceted set of interactions among prescribed drug types, dementia subtypes, and depression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01892-9. BioMed Central 2022-10-07 /pmc/articles/PMC9547465/ /pubmed/36207697 http://dx.doi.org/10.1186/s12911-022-01892-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Joshi, Alok
Todd, Stephen
Finn, David P.
McClean, Paula L.
Wong-Lin, KongFatt
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title_full Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title_fullStr Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title_full_unstemmed Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title_short Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
title_sort multi-dimensional relationships among dementia, depression and prescribed drugs in england and wales hospitals
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547465/
https://www.ncbi.nlm.nih.gov/pubmed/36207697
http://dx.doi.org/10.1186/s12911-022-01892-9
work_keys_str_mv AT joshialok multidimensionalrelationshipsamongdementiadepressionandprescribeddrugsinenglandandwaleshospitals
AT toddstephen multidimensionalrelationshipsamongdementiadepressionandprescribeddrugsinenglandandwaleshospitals
AT finndavidp multidimensionalrelationshipsamongdementiadepressionandprescribeddrugsinenglandandwaleshospitals
AT mccleanpaulal multidimensionalrelationshipsamongdementiadepressionandprescribeddrugsinenglandandwaleshospitals
AT wonglinkongfatt multidimensionalrelationshipsamongdementiadepressionandprescribeddrugsinenglandandwaleshospitals